KORU Medical amends bylaws to enhance stockholder nomination procedures

KORU Medical Systems, Inc.

Board unanimously adopted amended bylaws effective Feb 5, 2026.
Enhances procedural mechanics and disclosure for stockholder nominations and proposals.
Requires compliance with universal proxy Rule 14a-19 and additional disclosures from nominating stockholders.
Changes advance notice deadline for director nominations when board size increases.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

KORU Medical Systems, Inc.: Amended and restated bylaws to enhance procedural mechanics and disclosure requirements for stockholder nominations and proposals (effective 2026-02-05).

Change: bylaw amendment
Effective: 2026-02-05

Exact text from the filing

Effective February 5, 2026, the Board of Directors (the “Board”) of KORU Medical Systems, Inc. (the “Company”) unanimously adopted a resolution to amend and restate the Company’s By-laws in connection with the Securities and Exchange Commission rules regarding universal proxy cards and a periodic review of the bylaws.

View on SEC.gov

29 governance changes filed in the last 30 days. Browse all governance changes →

KORU Medical Systems, Inc. filing history →

Source: SEC EDGAR

accession 0001161697-26-000038

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.